MYCN and neoplasm: Recent studies show that high N-MYC protein and RNA levels could be better biomarkers than MYCN gene amplification in predicting the prognosis of neuroblastoma patients (44, 45), underscoring the importance of aberrant expression of N-MYC in tumor progression.